AstraZeneca Pledges $2 Billion to Expand Maryland Biomanufacturing, Creating Over 2,600 Jobs

AstraZeneca announced a $2 billion investment to expand its biomanufacturing facilities in Frederick and Gaithersburg, Maryland, creating over 2,600 jobs and marking the state's largest private capital investment in a decade.